Overview

To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets

Status:
Completed
Trial end date:
1992-10-01
Target enrollment:
Participant gender:
Summary
To demonstrate the relative bioequivalency comparing Geneva's 10 mg Glipizide tablets to Roerig's 10 mg Glucotrol tablets.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Glipizide